Since it has previously been suggested that the efficiency of MDM2 inhibitors can vary with species,35 we also treated the human osteosarcoma cell line SJSA-1, harboring wt p53, with Sulanemadlin, Siremadlin, and Navtemadlin. This evidence concerns the gene MDM2 and osteosarcoma.